Discontinued — last reported Q2 '23
Johnson & Johnson Consumer — Operating Income (Loss) increased by 10.8% to $860.00M in Q2 2023 compared to the prior quarter. Year-over-year, this metric grew by 9.7%, from $784.00M to $860.00M. This is a positive signal — higher values indicate stronger performance for this metric.
Higher operating income indicates strong operational efficiency and pricing power within the segment.
This represents the profit or loss generated by the Consumer Health segment after deducting operating expenses from reve...
Standard segment-level profitability metric used to compare operational efficiency across peers.
jnj_segment_consumer_health_operating_income_loss| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | |
|---|---|---|---|---|---|---|---|
| Value | $804.00M | -$636.00M | $686.00M | $784.00M | $809.00M | $776.00M | $860.00M |
| QoQ Change | — | -179.1% | +207.9% | +14.3% | +3.2% | -4.1% | +10.8% |
| YoY Change | — | — | — | -2.5% | +227.2% | +13.1% | +9.7% |